Ignite Creation Date:
2025-12-25 @ 2:37 AM
Ignite Modification Date:
2025-12-31 @ 4:31 PM
Study NCT ID:
NCT05518734
Status:
COMPLETED
Last Update Posted:
2023-03-30
First Post:
2022-08-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1 Dose Escalation Study of VX-708 in Healthy Participants
Sponsor:
Vertex Pharmaceuticals Incorporated
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-09-17
Start Date Type:
ACTUAL
Primary Completion Date:
2023-03-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-03-07
Completion Date Type:
ACTUAL
First Submit Date:
2022-08-25
First Submit QC Date:
None
Study First Post Date:
2022-08-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-03-29
Last Update Post Date:
2023-03-30
Last Update Post Date Type:
ACTUAL